Silencing of ENO1 gene in a breast cancer cell line reduced the proliferative capacity of the cells (Zhang et al., 2020), indicating that ENO1 could be a potential molecular prognostic marker or therapeutic target in breast cancer. Here, ENO1 is linked to breast carcinoma.